Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Journal of Virology|February 28, 2020
Dual Role of Toll-Like Receptor 7 in the Pathogenesis of Rabies Virus in a Mouse ModelZhaochen Luo, Lei Lv, Yingying Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 7, 2013
Glioma grade is associated with the accumulation and activity of cells bearing M2 monocyte markersMichael Prosniak, Larry A Harshyne, David W Andrews, et al.
Brain Research|April 30, 2019
Sphenopalatine ganglion stimulation is a reversible and frequency-dependent modulator of the blood-brain barrierRichard F Schmidt, Thana N Theofanis, Michael J Lang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 9, 2021
Systemic Immune Bias Delineates Malignant Astrocytoma Survival CohortsMichael Prosniak, Larry A Harshyne, Jonathan Gorky, et al.
Journal of Hematology & Oncology|September 25, 2016
Immune biomarkers of treatment failure for a patient on a phase I clinical trial of pembrolizumab plus radiotherapyGregory S Alexander, Joshua D Palmer, Madalina Tuluc, et al.
Cancer Biology & Therapy|January 26, 2025
Sigma1 inhibitor suppression of adaptive immune resistance mechanisms mediated by cancer cell derived extracellular vesiclesPaola A Castagnino, Derick A Haas, Luca Musante, et al.
Chronobiology International|May 25, 2002
Circadian variation in oxidative stress markers in healthy and type II diabetic menEugene L Kanabrocki, Dennis Murray, Ramon C Hermida, et al.
Cancer Biology & Therapy|June 27, 2024
Neuroendocrine gene subsets are uniquely dysregulated in prostate adenocarcinomaNicole M Naranjo, Anne Kennedy, Anna Testa, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|November 13, 2023
Targeting the αVβ3/NgR2 pathway in neuroendocrine prostate cancerAnna Testa, Fabio Quaglia, Nicole M Naranjo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2021
Phase Ib Clinical Trial of IGV-001 for Patients with Newly Diagnosed GlioblastomaDavid W Andrews, Kevin D Judy, Charles B Scott, et al.
Pageof 7